(1 day, 13 hours ago)
Commons ChamberI do not know how much credibility the hon. Gentleman has given to people whom he knows to be serial liars in his professional life. That is the issue. If the Prime Minister was on an interview panel—in a sense, he was; he was interviewing his close friend for a job—he must have known that he was talking to a serial liar.
We know that there is one thing that Mandelson did not lie about, because the Prime Minister knew it and said so today: that he continued his contact with Jeffrey Epstein after he was convicted as a paedophile. There were no lies in that, and the Prime Minister admitted that he knew it. Defend that!
My hon. Friend makes a point that is typically made in court. When the defendant is found to be lying, one addresses the jury and says, “He has lied about that, members of the jury. How can you trust him to tell the truth about the charge that he is facing?” In public office, serial liars should not be tolerated.
And if the Government cannot give a straight answer to my right hon. Friend’s question, that is another reason why we need a public inquiry.
My hon. Friend mentioned the revelations that are coming out of the emails. The point I made earlier—it is also very important that the Minister responds to this—is that the Government could have asked the US Department of Justice, “Is there anything in the emails relating to Mandelson that has not been released and could affect our decision to appoint him?” Nothing was stopping them from asking the DOJ that question, and it is vital that we know whether they did or not.
That is another very good point. I am sure that it has been picked up by Members on the Treasury Bench, and they will respond accordingly. In a sense, we have to thank our mercies that Mandelson has finally been exposed—and not just that exposure outside George Osborne’s house.
(1 year, 9 months ago)
Commons ChamberI agree that the benefits outweigh the risks, but I do not think we have ever had a system in this country where we license drugs on the basis that they will do more harm than good to those who take them. If the drugs are potentially significantly harmful to a large number of patients, those drugs do not get their licence—and why should they?
With respect, that is exactly what we do. Antibiotics cause anaphylactic reactions that kill people. We give antibiotics to people knowing that a very small portion of them will be killed by them but, overall, they save many more lives than they take. That is why they get a licence.
The key question is: do the people who are being prescribed the antibiotics know that there is a risk that they will die as a result of them being prescribed? If so, they are told that, but nobody who was affected by the covid-19 vaccines was told that they were anything other than absolutely safe and effective. That is the basis upon which a lot of the litigation will be founded.
I am most grateful to the hon. Gentleman for bringing his scientific expertise to the debate, because I am no scientist; I am a mere lawyer.
May I try to add some further clarity? There are actually a range of side effects, many of which occur over time. Ibuprofen, for instance, is another medicine that we might consider safe and call safe, and a large number of people take it, but eventually, after many years, some will suffer a stomach bleed that causes them to pass away as a result of taking too much ibuprofen over time, although that was medically allowed and considered to be safe. I am afraid that the attempt to give a scientific explanation is based on a flawed understanding of medicines and side effects, which has been demonstrated by numerous people on the other side of the debate.
I will not be able to adjudicate on whether my hon. Friend or the hon. Member for Kirkcaldy and Cowdenbeath (Neale Hanvey) is right, but I look forward to my hon. Friend’s being able to make his own speech and to its being subjected to scrutiny by the hon. Gentleman. That is a spectacle to which I think we are all looking forward.